» Articles » PMID: 28251655

The Vitamin D Metabolite Ratio (VMR) As a Predictor of Functional Biomarkers of Bone Health

Overview
Specialty Endocrinology
Date 2017 Mar 3
PMID 28251655
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Context: The vitamin D metabolite ratio (VMR) (serum 24,25(OH) D /25(OH)D ) has been proposed as a biomarker of vitamin D sufficiency to replace serum 25(OH)D.

Objective: To examine the relationships of 24,25(OH) D and VMR to functional biomarkers of bone health following vitamin D supplementation.

Setting: An ambulatory research centre.

Design: Serum from a previous research study of dose response of PTH, calcium absorption and bone turnover to vitamin D supplementation was analysed for vitamin D metabolites (25(OH)D, 24,25(OH) D ).

Outcome: The relationship of serum 24,25(OH) D and VMR to calcium absorption, PTH and bone turnover markers was examined.

Results: Although there were strong correlations of serum 25(OH)D with 24,25(OH) D and free 25(OH)D, its correlation with VMR was lower. After vitamin D supplementation, the change in 25(OH)D, 24,25(OH) D and VMR was associated with the change in calcium absorption, PTH and CTX. The correlation of the change in PTH with the change in metabolites was the lowest for VMR. Moreover, estimated dose response for standardized values of vitamin D metabolites showed a beta-coefficient for VMR that was significantly less in magnitude compared to other metabolites.

Conclusion: Serum 24,25(OH) D is closely associated with the dose response of serum 25(OH)D to vitamin D supplementation. However, the VMR does not appear to be equivalent to either of these metabolites in its response to increasing vitamin D intake or its association with PTH. It is unlikely that VMR will replace 25(OH)D as a biomarker for vitamin D sufficiency.

Citing Articles

Short-Term Effects of Escalating Doses of Cholecalciferol on FGF23 and 24,25(OH) Vitamin D Levels: A Preliminary Investigation.

Pepe J, Colangelo L, Pilotto R, De Martino V, Ferrara C, Scillitani A Nutrients. 2024; 16(21).

PMID: 39519433 PMC: 11547203. DOI: 10.3390/nu16213600.


Investigation of the Vitamin D Metabolite Ratio (VMR) as a Marker of Functional Vitamin D Deficiency: Findings from the SarcoPhAge Cohort.

Ladang A, Gendebien A, Kovacs S, Demonceau C, Beaudart C, Peeters S Nutrients. 2024; 16(19).

PMID: 39408192 PMC: 11478400. DOI: 10.3390/nu16193224.


Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy.

Stephan C, Ralla B, Bonn F, Diesner M, Lein M, Jung K Cancers (Basel). 2022; 14(6).

PMID: 35326710 PMC: 8946001. DOI: 10.3390/cancers14061560.


Vitamin D Metabolites: Analytical Challenges and Clinical Relevance.

Alonso N, Zelzer S, Eibinger G, Herrmann M Calcif Tissue Int. 2022; 112(2):158-177.

PMID: 35238975 PMC: 8892115. DOI: 10.1007/s00223-022-00961-5.


Factors Associated with Serum Vitamin D Metabolites and Vitamin D Metabolite Ratios in Premenopausal Women.

Toribio M, Priego-Capote F, Perez-Gomez B, Fernandez de Larrea-Baz N, Ruiz-Moreno E, Castello A Nutrients. 2021; 13(11).

PMID: 34836003 PMC: 8621214. DOI: 10.3390/nu13113747.


References
1.
Hoofnagle A, Eckfeldt J, Lutsey P . Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry. N Engl J Med. 2015; 373(15):1480-2. PMC: 4654614. DOI: 10.1056/NEJMc1502602. View

2.
Cashman K, Hayes A, Galvin K, Merkel J, Jones G, Kaufmann M . Significance of serum 24,25-dihydroxyvitamin D in the assessment of vitamin D status: a double-edged sword?. Clin Chem. 2015; 61(4):636-45. DOI: 10.1373/clinchem.2014.234955. View

3.
Cauley J, Danielson M, Boudreau R, Barbour K, Horwitz M, Bauer D . Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women's Health Initiative (WHI). J Bone Miner Res. 2011; 26(10):2378-88. PMC: 3304434. DOI: 10.1002/jbmr.449. View

4.
Kaufmann M, Gallagher J, Peacock M, Schlingmann K, Konrad M, Deluca H . Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. J Clin Endocrinol Metab. 2014; 99(7):2567-74. PMC: 4079315. DOI: 10.1210/jc.2013-4388. View

5.
Nielson C, Jones K, Chun R, Jacobs J, Wang Y, Hewison M . Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations. J Clin Endocrinol Metab. 2016; 101(5):2226-34. PMC: 4870848. DOI: 10.1210/jc.2016-1104. View